Funded Investigators

 

 

Over the course of the Foundation's 35-year history, we have funded more than 175 researchers all over the world.

Read about our funded investigators by clicking on the names below...

 

Tumor Dormancy

- Julio A. Aguirre-Ghiso, Ph.D., Icahn School of Medicine at Mount Sinai

- Eduardo F. Farias, Ph.D., Icahn School of Medicine at Mount Sinai 

- Emily Bernstein, Ph.D., Icahn School of Medicine at Mount Sinai
 

Brain Cancer 

- Albert S. Baldwin Jr., Ph.D., University of North Carolina, Chapel Hill

Mark Lemmon, Ph.D., University of Pennsylvania

Kevan Shokat, Ph.D., University of California, San Francisco

William Weiss, M.D., Ph.D., University of California, San Francisco

 

Cancer Stem Cells 

- Nabeel Bardeesy, Ph.D., Massachusetts General Hospital

Margaret Goodell, Ph.D., Baylor College of Medicine

 

Developing Epigenetic Therapy 

Stephen Baylin, M.D., Johns Hopkins University

Anthony Capobianco, Ph.D., University of Miami

Robert A. Casero, Ph.D., Johns Hopkins University

Sai-Juan Chen, M.D., Ph.D., Shanghai Institute of Hematology

Jonathan D. Licht, M.D., Northwestern University

Alexander MacKerrell, Ph.D., University of Maryland

Ari Melnick, M.D., Weill Cornell Medical Center

Wilson Miller, M.D., Ph.D., Jewish General Hospital

Gilbert Privé, Ph.D., University of Toronto

Frank Rauscher III, Ph.D., Wistar Institute

Ruibao Ren, M.D., Ph.D., Brandeis University

Arthur Zelent, Ph.D., Sylvester Comprehensive Cancer Center, University of Miami

Ming-Ming Zhou, Ph.D., Mount Sinai School of Medicine

 

Blood Malignancies

Ravi Bhatia, M.D., City of Hope

Brad Cairns, Ph.D., University of Utah

Scott Hiebert, Ph.D., Vanderbilt University

Yongkui Jing, Ph.D., Mount Sinai School of Medicine

David Jones, Ph.D., University of Utah

Ross Levine, M.D., Memorial Sloan-Kettering Cancer Center

Warren Pear, M.D., Ph.D., University of Pennsylvania

- Yang Shi, Ph.D., Boston Children's Hospital and Harvard Medical School

 

Childhood and Young Adult Cancers 

James E. Bradner, M.D., Dana-Farber Cancer Institute

John Crispino, Ph.D., Northwestern University

Christopher A. French, M.D., Brigham & Women's Hospital

Alan Friedman, M.D., Johns Hopkins University

Shai Izraeli, M.D., Tel Aviv University

Kevan Shokat, Ph.D., University of California, San Francisco

Erwin G. Van Meir, Ph.D., Emory University School of Medicine

 

Lung Cancer 

Duane Compton, Ph.D., Geisel School of Medicine/Dartmouth

Ethan Dmitrovsky, M.D., MD Anderson Cancer Center

Paul B. Fisher, Ph.D., Virginia Commonwealth University

 

Colon Cancer 

Ronald M. Evans, Ph.D., Salk Institute

Reuben Shaw, Ph.D., Salk Institute

 

Breast Cancer 

- Jayanta Debnath, M.D., University of California, San Francisco

Doris Germain, Ph.D., Mount Sinai School of Medicine

Samuel Waxman, M.D., Mount Sinai School of Medicine

Cynthia Zahnow, Ph.D., Johns Hopkins University

Robert A. Weinberg, Ph.D., Whitehead Institute for Biomedical Research

 

Ovarian Cancer 

Benjamin G. Neel, M.D., Ph.D., Ontario Cancer Institute

Garry P. Nolan, Ph.D., Stanford University School of Medicine

 

Pancreatic Cancer

- Nabeel Bardeesy, Ph.D., Massachusetts General Hospital

- Gregory David, Ph.D., NYU School of Medicine

 

Liver Cancer

Josep M. Llovet, M.D., Mount Sinai School of Medicine

Devanand Sarkar, MBBS, Ph.D., Virginia Commonwealth University

 

Hematology

Yang Shen, Ph.D., Shanghai Institute of Hematology

Zhu Chen, M.D., PhD., Shanghai Institute of Hematology

Yue Xiong, Ph.D., University of North Carolina, Chapel Hill

Jiang Zhu, Ph.D., Shanghai Institute of Hematology